PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-240

  1. 281 Posts.
    lightbulb Created with Sketch. 27
    I couldnt have said it any better myself. This would be another bad look to add to the list. Dont get me wrong, i am content holding my bag because i know the potential but one has to take considerations when management appears shacky.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.